index,hot,title,href
1,,"泸州老窖的""鬼故事""",http://xueqiu.com/1543205529/299833027
2,,创新药的暴利新玩法,http://xueqiu.com/1013597948/304800983
3,,从大朝山水电站说起水电股的投资价值,http://xueqiu.com/2054834210/304779301
4,,宁德时代为何对光伏与锂矿频频出手？莫非行业洗牌即将结束？,http://xueqiu.com/7866187817/304786252
5,,从伊利24H1看液奶行业：被周期掩盖的消费升级,http://xueqiu.com/4442967723/304764818
6,,SMMT将被收购 下一个会是康方生物吗,http://xueqiu.com/1638377010/304773712
7,,拼多多投资笔记,http://xueqiu.com/7018216825/304754159
8,,A股出现五个见底的信号,http://xueqiu.com/1843761023/304773140
9,,茅台扩产进行到哪了？,http://xueqiu.com/8959246745/304747264
10,,一图告诉你为什么我选择更低估的港股,http://xueqiu.com/3491589810/304741100
11,,浅谈中芯国际（略长）,http://xueqiu.com/6358651299/304721942
12,,不像日本，更似韩国,http://xueqiu.com/1039527614/304749089
13,,猪猪--13.7的成本，该骂不该骂,http://xueqiu.com/6022681001/304721558
14,,起立鼓掌，躬身前行：万字详解AK112与K药单药头对头PFS数据,http://xueqiu.com/1335311504/304654547
15,,投资风险&过程&结果,http://xueqiu.com/2792218779/304730063
16,,时人当识凌云木：简析康方生物AK112+AK117对MSS CRC治疗的迭代潜力,http://xueqiu.com/2693678800/304606852
17,,杠杠是把双刃剑,http://xueqiu.com/1707706450/304727955
18,,A股牛熊启示录,http://xueqiu.com/7708198303/304721741
19,,关于航空制造业景气拐点的一些看法。,http://xueqiu.com/2979842247/304710427
20,,新兴行业成长股不同渗透率下面的投资标的变化,http://xueqiu.com/5647126168/304694335
